-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The main risk factors for gallstone disease (GD) are female sex, pregnancy, genetic predisposition factors, contraception and obesi.
The main risk factors for gallstone disease (GD) are female sex, pregnancy, genetic predisposition factors, contraception and obesi.
We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) of patients following bariatric surgery using UD.
Results of the study showed that prophylactic use of UDCA was associated with (i) a reduction in gallstone formation (OR=25, 95%CI=21–31), and (ii) a reduction in the incidence of symptomatic gallstone disease (GD) ( OR=29, 95%CI=20–42), (iii) and cholecystectomy rate was also reduced (OR=33, 95%CI=20–5
prevention
This study demonstrates that prophylactic use of UDCA after bariatric surgery prevents gallstone formation and symptomatic GD and reduces the risk of cholecystecto.
This study demonstrates that prophylactic use of UDCA after bariatric surgery prevents gallstone formation and symptomatic GD and reduces the risk of cholecystecto.
Original source:
Andrea Mulli.
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled tria.
Leave a comment here